ALBO
Asset Logo

Albion Resources Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Albion Resources Limited - Option Expiring 29-Sep-2023

📈 Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.01

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in ALBO

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in ALBO

N/A
ALBO investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in ALBO also invest in...

Want more shares? Try these...

Alcidion Group Limited

ALC

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. Its principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Its other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users. The firm services over 400 hospitals.

📊 Share price

$0.10 AUD
Find Out More

Ampol Ltd. engages in the supply of transport fuels. The company is headquartered in Sydney, New South Wales and currently employs 2,549 full-time employees. The firm is primarily involved in the purchase, refining, distribution and marketing of petroleum products and the operation of convenience stores. The Company’s segment includes Convenience Retail, Fuels and Infrastructure, and Z Energy. Its Convenience Retail segment includes revenues and costs associated with fuels and shop offerings at Ampol’s network of stores, including royalties and franchise fees on remaining franchise stores. Its Fuels and Infrastructure segment includes revenues and costs associated with the integrated wholesale fuels and lubricants supply for the Company, including the Company’s international businesses, which consists of lytton refining, bulk fuels sales, trading and shipping, infrastructure, and Sea oil businesses. The Z Energy segment includes revenue and costs associated with fuel offerings in the New Zealand market.

📊 Share price

$31.78 AUD

Arovella Therapeutics Ltd. develops pharmaceuticals and distributes medical devices and consumables. The company is headquartered in Perth, Western Australia. The company went IPO on 2002-01-24. The firm is focused on developing therapies to treat human disease. The firm focuses two focus areas are oncology and conditions that impact the central nervous system. The Company’s technology includes iNKT Cell Therapy, DKK1-CAR-iNKT, AR19-iNKT + CF33-CD19, Anagrelide and ZolpiMist. The Company’s invariant natural killer T (iNKT) cell therapy pipeline through the license to the DKK1 monoclonal antibody (mAb). The company develops the DKK1 mAb as a chimeric antigen receptor to use in combination with its iNKT cell therapy platform. The firm is developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. Anagrelide is for the treatment of metastatic disease granted in the United States, Europe, Japan and Australia. ZolpiMist is an oral spray of zolpidem tartrate to treat short- term insomnia.

📊 Share price

$0.05 AUD

Albion Resources Ltd. is focused on exploration for lead, zinc, gold, and nickel. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-04-30. The firm's projects include Mongers Lake Project, Lennard Shelf Project and Leinster Project. The Lennard Shelf Project is located in the Mississippi Valley type zinc-lead province, the Lennard Shelf, approximately 30 kilometers (km) southeast of Fitzroy Crossing in the Kimberley, Western Australia. The Lennard Shelf Project includes three sub-projects, covering an expansive area of over 319 square kilometers (km2) and contains comparable geology to Pillara and the Cadjebut Trend. The Leinster Project is located over 30 km southeast of Leinster, covers an area of 42 km2. The Mongers Lake Project covers a portion of the Yalgoo-Singleton Greenstone Belt in the Murchison Province of Western Australia, located between Capricorn Metals’ Mt Gibson Gold Project and Silver Lakes’ Rothsay Gold Project.

📊 Share price

$0.07 AUD
Compare
Add to watchlist